932041-13-9 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 7-fluoro-1H-indazole-3-carboxylate is utilized as an intermediate in the synthesis of various pharmaceutical products. Its potential as a building block in drug development is attributed to its reactivity and versatile chemical properties, which facilitate the creation of new and innovative medications.
Used in Medicinal Chemistry Research and Development:
Methyl 7-fluoro-1H-indazole-3-carboxylate is also employed in the field of medicinal chemistry for research and development purposes. Its unique properties and reactivity make it an essential tool for scientists and researchers working on the discovery and improvement of pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 932041-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,2,0,4 and 1 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 932041-13:
(8*9)+(7*3)+(6*2)+(5*0)+(4*4)+(3*1)+(2*1)+(1*3)=129
129 % 10 = 9
So 932041-13-9 is a valid CAS Registry Number.
932041-13-9Relevant academic research and scientific papers
INDAZOLE- AND PYRROLOPYRIDINE-DERIVATIVE AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 182; 183, (2013/02/27)
The present invention relates to a novel indazole- or pyrrolopyridine-derivative, represented by the formula (1) below, that has an agonistic action or a partial agonistic action against serotonin-4 receptor, and a pharmaceutical composition comprising the same. Formula (1) [wherein each substituent is as defined in claim 1]
INDAZOLE DERIVATIVES
-
, (2011/02/25)
This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a
CONDENSED PYRAZOLE DERIVATIVES AS PPAR AGONISTS II
-
Page/Page column 16, (2010/11/26)
The invention discloses compounds of formula (I) wherein: R is a carboxylic acid or a derivative thereof; R1 and R2 are independently H or alkyl, or together R1 and R2 form an alkylene group; L1 is a
